Webinar
The Next Consumer AI Wave: From Chatbots to Personal Agents
Join Matt Caspari, Managing Partner at Alumni Ventures, as he explores the evolution of consumer AI from reactive chatbots to personalized agents — and what this shift could mean for the next generation of category-defining companies.
Matt will examine how consumer AI is moving beyond standalone chat interfaces toward personal agents designed to understand context, anticipate needs, and help users take action. He’ll discuss why this transition could reshape how people interact with technology and where new venture opportunities may emerge as AI becomes more integrated into everyday life.
Whether you’re an investor tracking the next wave of AI innovation, a founder building AI-native products, or simply interested in how personal agents could transform the consumer landscape, this session will offer a forward-looking view of the market’s evolution. Register to hear Matt’s perspective on the technologies and investment themes shaping the move from chatbots to personal agents.
Want to access our AI First Fund startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeUnderstand how consumer AI is evolving from conversational tools into personalized agents
- HomeLearn how a deep tech investor evaluates the technologies and opportunities emerging from this transition
- HomeExplore how accredited investors can access startups helping shape the next consumer AI wave
Rated a Top 20 VC Firm by both TIME and CB Insights.
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).